Nordson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Aug 20, 2025, 9:09 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The anticipated earnings increase and revenue growth reflect strong fundamentals. In the past, similar growth forecasts contributed to positive stock performance.
AI summary
What happened, with direct paths to the underlying reporting
NDSN expected to report $2.64 earnings per share for Q3. Revenue projection stands at $723.57 million, showing growth. Analysts maintain positive outlook with several upgrades and increased price targets. Shares gained 1.6% recently, closing at $217.50. Past performance shows solid growth, enhancing investor confidence.
NDSN expected to report $2.64 earnings per share for Q3.
Revenue projection stands at $723.57 million, showing growth.
Analysts maintain positive outlook with several upgrades and increased price targets.
Shares gained 1.6% recently, closing at $217.50.
Past performance shows solid growth, enhancing investor confidence.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Nordson reported better-than-expected Q3 results and raised FY26 guidance, signaling improved demand and/or margin execution. The raise provides a near-term catalyst for the stock…
NDSN to report Q4 earnings on Dec. 11, expected at $2.59 per share. Projected quarterly revenue of $736.79 million, up from last year's $719.31 million. NDSN offers a 1.23% annual…
NDSN's Q3 earnings outperformed estimates at $2.41 per share. Acquisition of Atrion Corporation enhances NDSN's medical product portfolio. Revenues grew 2% to $661.6M, driven by I…
- Nordson Corporation to acquire Atrion Corporation for $460.00 per share in cash. - Atrion generated revenues of about $169 million in 2023. - Acquisition will expand NDSN's medi…